Page 1 of Clinical Trials for Drug 2.5 mg NX-1207, 4 Total Matches
- 1CompletedPhase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)Last Updated: September 10, 2010Condition(s): Benign Prostatic Hyperplasia (BPH); Enlarged Prostate
- 2RecruitingLast Updated: March 1, 2012Condition(s): Benign Prostatic Hyperplasia
- 3RecruitingLast Updated: March 30, 2012Condition(s): Benign Prostatic Hyperplasia
- 4RecruitingLast Updated: March 30, 2012Condition(s): Benign Prostatic Hyperplasia (BPH)
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+2.5+mg+NX-1207
